Nanobiotix S.A. NNBXF OTC

Other OTC • Healthcare • Biotechnology • FR • USD

SharesGrow Score

30/100

0/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Nanobiotix S.A. (NNBXF) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 27/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

30/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

25/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

35/100

→ Income

GROWTH

58/100

→ Income

—

INCOME

N/A

No coverage

Valuation Snapshot — NNBXF

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.00

EV/EBITDA0.0

Per Share Data

EPS (TTM)$-1.44

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2015	$-1.20	$4.02M	$-17M	-423.5%
2016	$-1.43	$5.42M	$-21.88M	-403.6%
2017	$-1.50	$3.72M	$-26.14M	-702.4%
2018	$-1.55	$3.48M	$-30.35M	-872.2%
2019	$-2.35	$68K	$-50.92M	-74875%
2020	$-1.38	$50K	$-33.59M	-67180%
2021	$-1.35	$10K	$-47M	-470030%
2022	$-1.64	$4.78M	$-57.04M	-1194.3%
2023	$-1.08	$30.06M	$-39.7M	-132.1%
2024	$-1.44	$-11.61M	$-68.13M	-